Product Images Camptosar
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Camptosar NDC 0009-7529 by Pharmacia & Upjohn Company Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - camptosar 01
Figure 1 - camptosar 02
Figure 2 - camptosar 03
This appears to be a chart or graph depicting survival rates over time for a study involving Irinotecan and 5-FU/LV. The x-axis shows months and the y-axis represents survival probability. However, without more context or information it is difficult to interpret the chart accurately.*
Figure 3 - camptosar 04
Figure 4 - camptosar 05
This is a comparison study of Irinotecan and 5-FU in 127 and 129 individuals respectively. The median follow-up period was 15 months. However, due to the limited text, it is not clear what the numbers under "Median (mo)" represent. There is mention of a log-rank test and months, but no details are provided about what this means.*
Logo - camptosar 06
This is a description of a product called "Injectables". The product is distributed by a company named "Pharmacia & Upjohn Co", which is a division of "Pfizer Inc" located in NY, NY 10017.*
PRINCIPAL DISPLAY PANEL - 100 mg/5 mL Vial Label - camptosar 07
This is a description of a medication called Camptosar® (irinotecan HCI injection) used for intravenous use only. It comes in a Cytosafe® vial, contains 100mg/5mL (20mg/mL) of a sterile, aqueous solution and should be stored at room temperature between 15°C to 30°C (59° to 86°F) while being protected from light and freezing. The packaging warns that it is a cytotoxic agent and advises to discard any unused portion. The dosage and use instructions can be found in the accompanying prescribing information. It is distributed by Pharmacia & Upjohn Co division of Pfizer Inc in New York, NY and was made in Australia. There is a lot and expiration date on the packaging as well.*
PRINCIPAL DISPLAY PANEL - 100 mg/5 mL Vial Carton - camptosar 08
Camptosar® is an injectable medication for intravenous use only, containing irinotecan hydrochloride. It is a cytotoxic agent, used for cancer treatment, specifically, metastatic colorectal cancer. The dosage and use of Camptosar® must be determined according to the prescribing information. The medication should be stored at a controlled room temperature between 16°C to 30°C and protected from light, freezing, and damage or leakage in transit. The package is for a single-dose only and unused portions must be discarded, as per instructions.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.